You are here

Article Text

Article menu
Download PDFPDF
Leading article
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

https://doi.org/10.1136/gutjnl-2011-301133

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Correction notice This paper has been modified since it was first published online. All references from 57 onwards have been corrected.

    • Competing interests LB declares paid participation to advisory boards or educational activities for Abbott, Ferring Pharmaceuticals and MSD.

    • Provenance and peer review Commissioned; externally peer reviewed.